BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20859261)

  • 1. AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice.
    Dodge JC; Treleaven CM; Fidler JA; Hester M; Haidet A; Handy C; Rao M; Eagle A; Matthews JC; Taksir TV; Cheng SH; Shihabuddin LS; Kaspar BK
    Mol Ther; 2010 Dec; 18(12):2075-84. PubMed ID: 20859261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity.
    Dodge JC; Haidet AM; Yang W; Passini MA; Hester M; Clarke J; Roskelley EM; Treleaven CM; Rizo L; Martin H; Kim SH; Kaspar R; Taksir TV; Griffiths DA; Cheng SH; Shihabuddin LS; Kaspar BK
    Mol Ther; 2008 Jun; 16(6):1056-64. PubMed ID: 18388910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.
    Park S; Kim HT; Yun S; Kim IS; Lee J; Lee IS; Park KI
    Exp Mol Med; 2009 Jul; 41(7):487-500. PubMed ID: 19322031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of scAAV9-IGF1 extends survival in SOD1
    Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
    Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
    Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
    Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.
    Franz CK; Federici T; Yang J; Backus C; Oh SS; Teng Q; Carlton E; Bishop KM; Gasmi M; Bartus RT; Feldman EL; Boulis NM
    Neurobiol Dis; 2009 Mar; 33(3):473-81. PubMed ID: 19135533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis.
    Brockington A; Wharton SB; Fernando M; Gelsthorpe CH; Baxter L; Ince PG; Lewis CE; Shaw PJ
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):26-36. PubMed ID: 16410746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene and protein therapies utilizing VEGF for ALS.
    Keifer OP; O'Connor DM; Boulis NM
    Pharmacol Ther; 2014 Mar; 141(3):261-71. PubMed ID: 24177067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study on the distribution of insulin-like growth factor I (IGF-I) receptor in the central nervous system of SOD1(G93A) mutant transgenic mice.
    Chung YH; Joo KM; Shin CM; Lee YJ; Shin DH; Lee KH; Cha CI
    Brain Res; 2003 Dec; 994(2):253-9. PubMed ID: 14642651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
    Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
    Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector.
    Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C
    Brain Res Bull; 2019 Jan; 144():1-13. PubMed ID: 30414993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.
    Henriques A; Pitzer C; Dittgen T; Klugmann M; Dupuis L; Schneider A
    Mol Ther; 2011 Feb; 19(2):284-92. PubMed ID: 21139572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS.
    Lepore AC; Haenggeli C; Gasmi M; Bishop KM; Bartus RT; Maragakis NJ; Rothstein JD
    Brain Res; 2007 Dec; 1185():256-65. PubMed ID: 17963733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.
    Kaspar BK; Lladó J; Sherkat N; Rothstein JD; Gage FH
    Science; 2003 Aug; 301(5634):839-42. PubMed ID: 12907804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats.
    Dagvajantsan B; Aoki M; Warita H; Suzuki N; Itoyama Y
    Tohoku J Exp Med; 2008 Apr; 214(4):303-10. PubMed ID: 18441505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.